article thumbnail

Create Health Ventures Launches $21M Fund to Invest in Digital Health Startups

HIT Consultant

Additionally, the pharmaceutical industry’s increased focus on clinical trials presents a substantial opportunity for digital health solutions. – Advocatia : Simplifies the financial assistance experience and helps more patients enroll in Medicaid and other programs such as nutrition assistance and home energy assistance.

article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

The AI revolution has been and will continue to redefine the pharmaceutical industry in 2024, promising transformative outcomes for patients. Jason Rose, CEO at Adhere Health 2024 will spark transformational change across the pharmaceutical industry. Dave Latshaw, CEO at BioPhy 1.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Q/A: DocStation CEO Shares How AI Will Help Pharmacies Use the DIR Fee Changes to Their Advantage

HIT Consultant

Samm Anderegg, Co-Founder & CEO at DocStation Early next year, the Centers for Medicare and Medicaid Services (CMS) will remove the application of retroactive DIR fees and move DIR fees to the point of sale instead. What opportunities will AI offer the pharmaceutical industry to make further progress concerning PBMs and their DIR fees?

article thumbnail

Why Health Systems Need a New Transition Strategy to APMs

HIT Consultant

She jokes that she has occupied a seat in every healthcare position except for the pharmaceutical industry.

article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy 

Bill of Health

Comparison of Research Spending on New Drug Approvals by the National Institutes of Health vs the Pharmaceutical Industry, 2010-2019. Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020. A full posting of abstracts/summaries of these articles may be found on our  website.

article thumbnail

Pharmaceutical industry rips 'draconian' price negotiation provision

Fierce Healthcare

The Biden administration and federal regulators may be taking a victory lap following the unveiling of the Centers for Medicare & Medicaid Services’ (CMS') price negotiations list, but major pl | Critics of President Joe Biden's policies to rein in prices for 10 Medicare Part D drugs believe the policy is "draconian" and will (..)

article thumbnail

Pharma – 2023 Health IT Predictions

Healthcare IT Today

This could be a breakthrough for the pharmaceutical industry. Lauren Ohlsson, Lead of Industry Solutions – Pharmaceuticals & Healthcare at VDX.tv. In 2023, PLD (Physician Level Data) reporting from digital media partners will become increasingly essential to pharmaceutical organizations.